The downfall of TBA-354 – a possible explanation for its neurotoxicity via mass spectrometric imaging

References

• Andersson M, Groseclose MR, Deutch AY, et al. (2008). Imaging mass spectrometry of proteins and peptides: 3D volume reconstruction. Nat Methods 5:101–8.
   PubMed Web of Science ®Google Scholar
• Arnaud CH. (2017). Pharma embraces imaging mass spec [online]. C&EN Chemical & Engineering News. Available from: http://cen.acs.org/articles/95/i23/Pharma-embraces-imaging-mass-spec.html [last accessed 7 Jun 2017]
   Google Scholar
• Baijnath S, Naiker S, Shobo A, et al. (2015). Evidence for the presence of clofazimine and its distribution in the healthy mouse brain. J Mol Histol 46:439–42.
   PubMed Web of Science ®Google Scholar
• Baijnath S, Shobo A, Bester LA, et al. (2016). Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry. J Mol Histol 47:429–35.
   PubMed Web of Science ®Google Scholar
• Blohm M, Nürnberger W, Aulich A, et al. (1997). Reversible brain MRI changes in acyclovir neurotoxicity. Bone Marrow Transplant 19:1049–51.
   PubMed Web of Science ®Google Scholar
• Chan K, Lanthier P, Liu X, et al. (2009). MALDI mass spectrometry imaging of gangliosides in mouse brain using ionic liquid matrix. Anal Chim Acta 639:57–61.
   PubMed Web of Science ®Google Scholar
• Drexler DM, Garrett TJ, Cantone JL, et al. (2007). Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. J Pharmacol Toxicol Methods 55:279–88.
   PubMedGoogle Scholar
• Evarts EV, Tanji J. (1976). Reflex and intended responses in motor cortex pyramidal tract neurons of monkey. J Neurophysiol 39:1069–80.
   PubMed Web of Science ®Google Scholar
• Fernández JA, Ochoa B, Fresnedo O, et al. (2011). Matrix-assisted laser desorption ionization imaging mass spectrometry in lipidomics. Anal Bioanal Chem 401:29–51.
   PubMed Web of Science ®Google Scholar
• Hodgson PS, Neal JM, Pollock JE, et al. (1999). The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 88:797–809.
   PubMed Web of Science ®Google Scholar
• Hood JE, Jenkins JW, Milatovic D, et al. (2010). Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology 31:518–23.
   PubMed Web of Science ®Google Scholar
• I-Base. (2016). The tuberculosis treatment pipeline: activity, but no answers [online]. Available from: http://i-base.info/htb/30164 [last accessed 4 Oct 2016]
   Google Scholar
• Kadar H, Le Douaron G, Amar M, et al. (2014). MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain. Neurotox Res 25:135–45.
   PubMed Web of Science ®Google Scholar
• Koizumi S, Yamamoto S, Hayasaka T, et al. (2010). Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain. Neuroscience 168:219–25.
   PubMed Web of Science ®Google Scholar
• Lemon RN, Griffiths J. (2005). Comparing the function of the corticospinal system in different species: organizational differences for motor specialization? Muscle Nerve 32:261–79.
   PubMed Web of Science ®Google Scholar
• Little JW, Ditunno JF, Stiens SA, et al. (1999). Incomplete spinal cord injury: neuronal mechanisms of motor recovery and hyperreflexia. Arch Phys Med Rehabil 80:587–99.
   PubMed Web of Science ®Google Scholar
• McDonnell LA, Heeren RMA. (2007). Imaging mass spectrometry. Mass Spectrom Rev 26:606–43.
   PubMed Web of Science ®Google Scholar
• Mckeage MJ, Hsu T, Screnci D, et al. (2001). Nucleolar damage correlates with neurotoxicity induced by different platinum drugs. Br J Cancer 85:1219–25.
   PubMed Web of Science ®Google Scholar
• Nevin RL. (2014). Idiosyncratic quinoline central nervous system toxicity: historical insights into the chronic neurological sequelae of mefloquine. Int J Parasitol-Drug 4:118–25.
   PubMed Web of Science ®Google Scholar
• Nilsson A, Sköld K, Sjögren B, et al. (2007). Increased striatal mRNA and protein levels of the immunophilin FKBP-12 in experimental Parkinson's disease and identification of FKBP-12-binding proteins. J Proteome Res 6:3952–61.
   PubMed Web of Science ®Google Scholar
• Olney JW, Farber NB. (1995). NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13:335–45.
   PubMed Web of Science ®Google Scholar
• Papp. (2014). Rat-Waxholm Rat [online]. Available from: https://scalablebrainatlas.incf.org/rat/PLCJB14 [last accessed 14 Jul 2017]
   Google Scholar
• Pikov V, Mccreery DB. (2009). Spinal hyperexcitability and bladder hyperreflexia during reversible frontal cortical inactivation induced by low-frequency electrical stimulation in the cat. J Neurotrauma 26:109–19.
   PubMed Web of Science ®Google Scholar
• Roos JF, Bulitta J, Lipman J, et al. (2006). Pharmacokinetic–pharmacodynamic rationale for cefepime dosing regimens in intensive care units. J Antimicrob Chemother 58:987–93.
   PubMed Web of Science ®Google Scholar
• Schwamborn K, Caprioli RM. (2010). Molecular imaging by mass spectrometry-looking beyond classical histology. Nat Rev Cancer 10:639–46.
   PubMed Web of Science ®Google Scholar
• Shobo A, Baijnath S, Bratkowska D, et al. (2015a). MALDI MSI and LC–MS/MS: towards preclinical determination of the neurotoxic potential of fluoroquinolones. Drug Test Anal 8:832–8.
   PubMed Web of Science ®Google Scholar
• Shobo A, Bratkowska D, Baijnath S, et al. (2015b). Visualization of time-dependent distribution of rifampicin in rat brain using MALDI MSI and quantitative LCMS/MS. Assay Drug Dev Technol 13:277–84.
   PubMed Web of Science ®Google Scholar
• Shobo A, Bratkowska D, Baijnath S, et al. (2016). Tissue distribution of pretomanid in rat brain via mass spectrometry imaging. Xenobiotica 46:247–52.
   PubMed Web of Science ®Google Scholar
• Tb-Alliance. (2016). Phase 1 clinical trial of TB drug candidate TBA-354 discontinued [online]. TB Alliance. Available from: http://www.tballiance.org/news/phase-1-clinical-trial-tb-drug-candidate-tba-354-discontinued. [last accessed 20 May 2016]
   Google Scholar
• Trim PJ, Snel MF. (2016). Small molecule MALDI MS imaging: current technologies and future challenges. Methods 104:127–41.
   PubMed Web of Science ®Google Scholar
• Upton AM, Cho S, Yang TJ, et al. (2015). In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis. Antimicrob Agents Chemother 59:136–44.
   PubMed Web of Science ®Google Scholar
• Wisztorski M, Croix D, Macagno E, et al. (2008). Molecular MALDI imaging: an emerging technology for neuroscience studies. Dev Neurobiol 68:845–58.
   PubMed Web of Science ®Google Scholar